Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Wharton's jelly secretomes are best for promoting blood vessel growth.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Fullerenes show potential in skin care but need more safety research.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Pegvaliase is recommended for treating adults with phenylketonuria.